Chennai, April 19, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE:CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin PointLaboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Milrinone Lactate Injection USP, 10 mg/10 mL (1 mg/mL), 20 mg/20…
Madan Krishnan, Vice President, and MD, Indian Subcontinent, India Medtronic, said human capital is the asset adding to it, adoption of technology in a better way to achieve a goal of $5 trillion economy. The thriving automotive industry, flourishing digital economy, and the vast scope in academics are some of the X-factors of Tamil Nadu…
Chennai, January 22, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742),NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Argatroban Injection, 50 mg/50 ml (1 mg/ml) Single-dose vial presentation,…
Chennai, Jan 18, 2021: Caplin Point Laboratories Limited (BSE: CAPLL (524742), NSE: CAPLIPOINT) announced that Caplin Steriles Limited (a Subsidiary of Caplin Point Laboratories Ltd) has entered into a strategic partnership with JAMP Pharma Group for six injectable products to be filed shortly in Canada. Some of these products have already been filed by Caplin…
Chennai, December 24, 2020: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Etomidate injection USP, 20 mg/10 mL (2 mg/mL) and 40 mg/20 mL (2 mg/mL) Single-dose vial presentations, a generic therapeutic equivalent version of (RLD),…
Chennai, Mar 22, 2018: Caplin Point Laboratories Limited (BSE: CAPLL (524742),NSE: CAPLIPOINT) announced that Caplin Steriles Limited (a Wholly OwnedSubsidiary of Caplin Point Laboratories Ltd), has been granted final approval by the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Glycopyrrolate injection USP, 0.2mg/ml (in 1 ml, 2 ml,…
– Caplin Steriles will out-license five of its injectable AND As to Baxter Healthcare Corporation . Chennai, April 08,2019: Caplin Point Laboratories Limited (BSE: CAPLL (524742), NSE:CAPLIPOINT) announced that Caplin Steriles Limited (a Wholly Owned Subsidiary of Caplin Point Laboratories Ltd) has entered into a license and supply agreement with Baxter Healthcare Corporation for five…
08.05.2017Download
